Coyne Terrance P.
Insider CIK 1814876 · RPRX EVP & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | S Sale | 2026-08-13 | 2026-08-17 | 1,772 | $59.14 | $104.8K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-08-13 | 2026-08-17 | 9,230 | $58.59 | $540.8K | 1,772 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-08-13 | 2026-08-17 | 1,772 | $59.14 | $104.8K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-08-13 | 2026-08-17 | 9,230 | $58.59 | $540.8K | 1,772 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2026-08-07 | 2026-08-07 | 18,500 | — | $0 | 1,788,777 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2026-08-07 | 2026-08-07 | 18,500 | — | $0 | 1,788,777 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-08-05 | 2026-08-07 | 11,002 | — | $0 | 11,002 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-08-05 | 2026-08-07 | 11,002 | — | $0 | 11,002 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-05-26 | 2026-05-28 | 64,399 | $53.98 | $3.48M | 0 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-05-06 | 2026-05-08 | 24,263 | — | $0 | 64,399 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-04-28 | 2026-04-30 | 32,916 | $49.78 | $1.64M | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-04-28 | 2026-04-30 | 1,875 | $49.78 | $93.3K | 40,136 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-04-01 | 2026-04-02 | 1,875 | $48.33 | $90.6K | 42,011 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-04-01 | 2026-04-02 | 32,916 | $48.33 | $1.59M | 32,916 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-03-23 | 2026-03-25 | 1,875 | $45.53 | $85.4K | 43,886 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-03-23 | 2026-03-25 | 32,916 | $45.53 | $1.50M | 65,832 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-03-02 | 2026-03-04 | 583 | $47.01 | $27.4K | 45,761 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-03-02 | 2026-03-04 | 22,487 | $46.67 | $1.05M | 109,177 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-03-02 | 2026-03-04 | 10,429 | $47.01 | $490.3K | 98,748 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-03-02 | 2026-03-04 | 1,292 | $46.67 | $60.3K | 46,344 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-23 | 2026-02-25 | 1,875 | $45.32 | $85.0K | 47,636 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-23 | 2026-02-25 | 32,916 | $45.32 | $1.49M | 131,664 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-02-11 | 2026-02-13 | 26,626 | — | $0 | 49,511 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-04 | 2026-02-04 | 19,076 | $43.29 | $825.8K | 164,580 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-04 | 2026-02-04 | 1,087 | $43.29 | $47.1K | 22,885 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-03 | 2026-02-04 | 108,759 | $42.84 | $4.66M | 183,656 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-03 | 2026-02-04 | 6,195 | $42.84 | $265.4K | 23,972 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-02 | 2026-02-04 | 102,581 | $42.08 | $4.32M | 292,415 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-02-02 | 2026-02-04 | 5,843 | $42.08 | $245.9K | 30,167 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-20 | 2026-01-23 | 3,750 | $39.35 | $147.6K | 36,010 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-20 | 2026-01-23 | 65,832 | $39.35 | $2.59M | 394,996 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-02 | 2026-01-06 | 65,832 | $38.42 | $2.53M | 460,828 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-02 | 2026-01-06 | 3,750 | $38.42 | $144.1K | 39,760 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-15 | 2025-12-17 | 65,832 | $38.36 | $2.53M | 526,660 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-15 | 2025-12-17 | 3,750 | $38.36 | $143.8K | 43,510 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-01 | 2025-12-03 | 65,832 | $39.87 | $2.62M | 592,492 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-01 | 2025-12-03 | 3,750 | $39.87 | $149.5K | 47,260 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-24 | 2025-11-26 | 10,686 | $37.96 | $405.6K | 658,324 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-24 | 2025-11-26 | 3,126 | $38.67 | $120.9K | 51,634 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-24 | 2025-11-26 | 624 | $37.96 | $23.7K | 51,010 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-24 | 2025-11-26 | 55,146 | $38.67 | $2.13M | 669,010 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-17 | 2025-11-19 | 3,750 | $39.30 | $147.4K | 54,760 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-17 | 2025-11-19 | 65,844 | $39.30 | $2.59M | 724,156 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-11-05 | 2025-11-07 | 6,168 | — | $0 | 58,510 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2025-08-08 | 2025-08-08 | 1,000 | — | $0 | 43,350 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-08-06 | 2025-08-08 | 3,696 | — | $0 | 52,342 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2025-05-16 | 2025-05-20 | 1,807,277 | — | $0 | 1,807,277 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-08 | 2025-05-09 | 48,646 | — | $0 | 48,646 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2024-08-12 | 2024-08-12 | 2,000 | — | $0 | 44,350 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-08-10 | 2023-08-11 | 37,500 | $30.75 | $1.15M | 790,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-08-09 | 2023-08-11 | 37,500 | $30.72 | $1.15M | 827,500 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2023-08-08 | 2023-08-08 | 1,650 | — | $0 | 46,350 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-07-13 | 2023-07-14 | 37,500 | $30.93 | $1.16M | 865,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-07-12 | 2023-07-14 | 37,500 | $31.07 | $1.17M | 902,500 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-08 | 2022-11-10 | 24,500 | $43.47 | $1.07M | 940,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-02 | 2022-11-04 | 5,500 | $43.06 | $236.8K | 964,500 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-08-01 | 2022-08-03 | 30,000 | $43.19 | $1.30M | 970,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2021-05-07 | 2021-05-11 | 100,000 | — | $0 | 22,945 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2021-05-07 | 2021-05-11 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-03 | 2021-03-05 | 11,001 | $45.86 | $504.5K | 201,456 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-03 | 2021-03-05 | 29,820 | $43.71 | $1.30M | 270,180 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-03 | 2021-03-05 | 1,456 | $46.83 | $68.2K | 200,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-03 | 2021-03-05 | 57,723 | $45.09 | $2.60M | 212,457 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 5,022 | $47.88 | $240.5K | 300,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 94,978 | $46.89 | $4.45M | 305,022 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-12-31 | 2021-01-05 | 9,977 | — | $0 | 778 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-12-31 | 2021-01-05 | 30,023 | — | $0 | 376,468 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-12-31 | 2021-01-05 | 99,770 | — | $0 | 99,770 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-12-31 | 2021-01-05 | 300,230 | — | $0 | 400,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2021-01-05 | 2,417 | — | $0 | 188 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2021-01-05 | 24,170 | — | $0 | 24,170 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-23 | 2,327 | — | $0 | 181 | SEC↗ |
| RPRX Royalty Pharma plc | P Buy | 2020-06-18 | 2020-06-23 | 1,500 | $28.00 | $42.0K | 1,500 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-23 | 23,270 | — | $0 | 23,270 | SEC↗ |
| RPRX Royalty Pharma plc | P Buy | 2020-06-18 | 2020-06-23 | 1,450 | $28.00 | $40.6K | 1,450 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2021-01-05 | 2,605 | — | $0 | 2,605 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 48,000 | — | $0 | 48,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 305,000 | — | $0 | 305,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 2,508 | — | $0 | 2,508 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 406,491 | — | $0 | 406,491 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 10,755 | — | $0 | 10,755 | SEC↗ |